Published on November 2, 2026, in the journal EP Europace, the KSP-AF trial conducted by researchers at Kunming Medical University indicates that recognizing key spatiotemporal potentials—electrical signals during fibrillation—could allow for more precise choices in where to intervene, alongside standard pulmonary vein isolation. At two years, after a single procedure and without antiarrhythmic drugs, 74% of patients in the KSP-guided group did not have documented recurrences, compared to 48% in the group receiving pulmonary vein isolation alone.
In Plain English: The Clinical Takeaway
- Targeted Energy Delivery: Instead of treating only the pulmonary veins, this electrical mapping technique identifies specific signals that contribute to maintaining the arrhythmia, offering additional targets for ablation.
- Procedural Balance: Expanding the ablation area must be justified by a favorable ratio between benefits and risks, as a greater number of areas treated requires evaluation.
- Symptom Independence: The absence of physical palpitations does not guarantee freedom from arrhythmia; therefore, post-procedural monitoring and anticoagulant regimens must be managed according to individual risk, rather than patient comfort alone.
Mapping Functional Substrates Beyond Pulmonary Vein Isolation
Catheter ablation is a procedure with which a cardiologist intervenes, through catheters, on tissue involved in anomalous electrical signals. It is used when drugs are not sufficient or in selected patients; the most established strategy involves the electrical isolation of the pulmonary veins, from which the impulses that initiate fibrillation often originate. However, interrupting the propagation of these impulses toward the atria does not always prevent the arrhythmia from recurring.
This study examined whether early rhythm control after acute ischemic stroke was associated with a lower risk of recurrent stroke or systemic embolism in patients with atrial fibrillation. Read more: https://t.co/9VRMhK2ssQ pic.twitter.com/IGlLKvmjqF
To address this clinical limitation, researchers studied key spatiotemporal potentials, or KSPs: particular configurations of electrograms, which are recordings of cardiac electrical activity, recognizable for their temporal behavior during fibrillation. The hypothesis is that these signals allow for the identification of portions of tissue that contribute to maintaining the arrhythmia. By analyzing 93 cardiac regions across 18 patients, the research team observed a relative stability of the dominant frequency of signals over short intervals.
Clinical Trial Design and Two-Year Recurrence Outcomes
To test this hypothesis, the KSP-AF randomized trial enrolled 100 patients with paroxysmal or persistent atrial fibrillation undergoing their first ablation procedure. Participants were randomly assigned to receive either conventional pulmonary vein isolation alone or isolation paired with ablation of the areas identified through KSPs.
At the two-year mark, following a single procedure and without the administration of antiarrhythmic drugs, 74% of patients in the KSP-guided group did not have documented recurrences, compared to 48% in the control group—a difference of 26 percentage points. When considering together the absence of fibrillation and atrial tachycardia, the percentages were 68% and 46% respectively.
| Treatment Arm (N=100) | 2-Year Non-Recurrence Rate | Freedom from AF and Atrial Tachycardia |
|---|---|---|
| Pulmonary Vein Isolation + KSP Ablation | 74% | 68% |
| Pulmonary Vein Isolation Alone | 48% | 46% |
When to Consult a Doctor
The decision on the possible continuation of anticoagulants after ablation depends on the individual risk of thromboembolism, not only on the perception of a rhythm that has returned to normal. The improvement of the arrhythmia and the prevention of stroke are connected issues, but they are not overlapping.
Evaluating the Generalizability of KSP-Guided Ablation
The study concerns one hundred people treated in a single center. Multicenter studies are required to verify if the benefit is confirmed in different hospitals, with other operators, and on larger populations. Furthermore, it is necessary to evaluate the duration and risks of a more extensive ablation.
References
- Zhou M., Li L., Wu L. et al. “Behavior-Based Electrogram Mapping Identifies Potential Functional Substrates in Atrial Fibrillation: The KSP-AF Randomized Study”. EP Europace, 2 novembre 2026. DOI: 10.1093/europace/euag308
